Clinical efficacy of alternative TNF inhibitor and secukinumab between primary non-responder and secondary non-responder of prior TNF inhibitor in ankylosing spondylitis

To compare the drug retention times and clinical efficacy of alternative tumour necrosis factor inhibitors (TNFi) and secukinumab in primary and secondary non-responders with ankylosing spondylitis (AS). AS patients treated with biologics and enrolled in the Korean College of Rheumatology Biologics...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Modern rheumatology 2023-01, Vol.33 (1), p.194-201
Hauptverfasser:	Min, Hong Ki, Kim, Hae-Rim, Lee, Sang-Heon, Hong, Yeon Sik, Kim, Moon-Young, Park, Sung-Hwan, Kang, Kwi Young
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - therapeutic use Biological Products - therapeutic use Humans Spondylitis, Ankylosing - drug therapy Treatment Outcome Tumor Necrosis Factor Inhibitors - therapeutic use Tumor Necrosis Factor-alpha
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!